Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator SLUG
Molecular Medicine Reports · 2024
DOI: 10.3892/mmr.2024.13352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Medicine Reports, 2024. Verfasst von Ingridy Izabella Vieira Cardoso und 14 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo 14784400, Brazil. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Epithelial-Mesenchymal Transition, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Germ cell tumors (GCTs) constitute diverse neoplasms arising in the gonads or extragonadal locations. Testicular GCTs (TGCTs) are the predominant solid tumors in adolescents and young men. Despite cisplatin serving as the primary therapeutic intervention for TGCTs, 10‑20% of patients with advanced disease demonstrate resistance to cisplatin‑based chemotherapy, and epithelial‑mesenchymal transition (EMT) is a potential contributor to this resistance. EMT is regulated by various factors, including the snail family transcriptional repressor 2 (SLUG) transcriptional factor, and, to the best of our knowledge, remains unexplored within TGCTs. Therefore, the present study investigated the EMT transcription factor SLUG in TGCTs. In silico analyses were performed to investigate the expression of EMT markers in TGCTs. In addition, a cisplatin‑resistant model for TGCTs was developed using the NTERA‑2 cell line, and a mouse model was also established. Subsequently, EMT was assessed both in vitro and in vivo within the cisplatin‑resistant models using quantitative PCR and western blot analyses. The results of the in silico analysis showed that the different histologies exhibited distinct expression profiles for EMT markers. Seminomas exhibited a lower expression of EMT markers, whereas embryonal carcinomas and mixed GCT demonstrated high expression. Notably, patients with lower SLUG expression had longer median progression‑free survival (46.4 months vs. 28.0 months, P=0.022). In the in vitro analysis, EMT‑associated genes [fibronectin; vimentin (VIM); actin, α2, smooth muscle; collagen type I α1; transforming growth factor‑β1; and SLUG] were upregulated in the cisplatin‑resistant NTERA‑2 (NTERA‑2R) cell line after 72 h of cisplatin treatment. Consistent with this finding, the NTERA‑2R mouse model demonstrated a significant upregulation in the expression levels of VIM and SLUG. In conclusion, the present findings suggested that SLUG may serve a crucial role in connecting EMT with the development of cisplatin resistance, and targeting SLUG may be a putative therapeutic strategy to mitigate cisplatin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo 14784400, Brazil.
- Department of Pathology, Barretos Cancer Hospital, Barretos, São Paulo 14784400, Brazil.
- Barretos Children's Cancer Hospital, Hospital de Amor, Barretos, São Paulo 14784400, Brazil.
Zitieren
APA
Cardoso, I. I. V., Rosa, M. N., Moreno, D. A., Tufi, L. M. B., Ramos, L. P., Pereira, L. A. B., Silva, L., Galvão, J. M. S., Tosi, I. C., Lengert, A. V. H., Da Cruz, M. C., Teixeira, S. A., Reis, R. M., Lopes, L. F., & Pinto, M. T. (2024). Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator SLUG. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2024.13352
Vancouver
Cardoso IIV, Rosa MN, Moreno DA, Tufi LMB, Ramos LP, Pereira LAB, et al. Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator SLUG. Molecular Medicine Reports. 2024. doi:10.3892/mmr.2024.13352
BibTeX
@article{Cardoso2024,
author = {Cardoso, Ingridy Izabella Vieira and Rosa, Marcela Nunes and Moreno, Daniel Antunes and Tufi, Letícia Maria Barbosa and Ramos, Lorrayne Pereira and Pereira, Larissa Alessandra Bourdeth and Silva, Lenilson and Galvão, Janaina Mello Soares and Tosi, Isabela Cristiane and Lengert, André Van Helvoort and Da Cruz, Marcelo Cavalcanti and Teixeira, Silvia Aparecida and Reis, Rui Manuel and Lopes, Luiz Fernando and Pinto, Mariana Tomazini},
title = {Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator SLUG},
journal = {Molecular Medicine Reports},
year = {2024},
doi = {10.3892/mmr.2024.13352}
}
EUVIMED